Overview

Mirena Extension Trial

Status:
Completed
Trial end date:
2021-05-28
Target enrollment:
Participant gender:
Summary
The study is performed to assess if Mirena is effective and safe as a birth control method beyond 5 years of use. Further the menstrual blood loss (in women that had Mirena inserted for the indication heavy menstrual bleeding [HMB]) and safety will be assessed.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Levonorgestrel